ID   OLA1_HUMAN              Reviewed;         396 AA.
AC   Q9NTK5; D7EHM2; Q5BJD7; Q8NCI8; Q96CU1; Q96SV2; Q9P1D3; Q9UNY9; Q9Y6G4;
DT   25-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2002, sequence version 2.
DT   18-JUN-2025, entry version 213.
DE   RecName: Full=Obg-like ATPase 1 {ECO:0000255|HAMAP-Rule:MF_03167};
DE   AltName: Full=DNA damage-regulated overexpressed in cancer 45;
DE            Short=DOC45;
DE   AltName: Full=GTP-binding protein 9;
GN   Name=OLA1 {ECO:0000255|HAMAP-Rule:MF_03167}; Synonyms=GTPBP9;
GN   ORFNames=PRO2455, PTD004;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   INDUCTION.
RX   PubMed=20053727; DOI=10.1158/1541-7786.mcr-09-0278;
RA   Sun H., Luo X., Montalbano J., Jin W., Shi J., Sheikh M.S., Huang Y.;
RT   "DOC45, a novel DNA damage-regulated nucleocytoplasmic ATPase that is
RT   overexpressed in multiple human malignancies.";
RL   Mol. Cancer Res. 8:57-66(2010).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Yue P., Yu L., Zhao S.Y.;
RT   "Cloning of a new human cDNA homologous to Caenorhabditis elegans putative
RT   GTP-binding protein.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Amygdala;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pituitary tumor;
RA   Zhang Q., Huang Q., Song H., Peng J., Fu G., Mao M., Dai M., Mao Y.,
RA   Zhou J., Chen Z., Chen J., Luo M., Hu R.;
RT   "Human homologous yeast-44.2 protein, complete cds.";
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Fetal liver;
RA   Zhang C., Yu Y., Zhang S., Wei H., Zhou G., Ouyang S., Luo L., Bi J.,
RA   Liu M., He F.;
RT   "Functional prediction of the coding sequences of 121 new genes deduced by
RT   analysis of cDNA clones from human fetal liver.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain, Ovary, Testis, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-294, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) IN COMPLEX WITH ATP ANALOG, SUBUNIT,
RP   AND MUTAGENESIS OF PHE-127; ASN-230 AND 231-LEU--GLU-233.
RX   PubMed=17430889; DOI=10.1074/jbc.m700541200;
RA   Koller-Eichhorn R., Marquardt T., Gail R., Wittinghofer A., Kostrewa D.,
RA   Kutay U., Kambach C.;
RT   "Human OLA1 defines an ATPase subfamily in the Obg family of GTP-binding
RT   proteins.";
RL   J. Biol. Chem. 282:19928-19937(2007).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-168.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Hydrolyzes ATP, and can also hydrolyze GTP with lower
CC       efficiency. Has lower affinity for GTP. {ECO:0000255|HAMAP-
CC       Rule:MF_03167}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU01047};
CC   -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_03167,
CC       ECO:0000269|PubMed:17430889}.
CC   -!- INTERACTION:
CC       Q9NTK5; PRO_0000038593 [P04591]: gag; Xeno; NbExp=4; IntAct=EBI-766468, EBI-6179719;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03167,
CC       ECO:0000269|PubMed:20053727}. Nucleus {ECO:0000255|HAMAP-Rule:MF_03167,
CC       ECO:0000269|PubMed:20053727}. Nucleus, nucleolus {ECO:0000255|HAMAP-
CC       Rule:MF_03167, ECO:0000269|PubMed:20053727}. Note=Predominantly
CC       cytoplasmic, shuttles between the nucleus and the cytoplasm.
CC       {ECO:0000255|HAMAP-Rule:MF_03167}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9NTK5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NTK5-2; Sequence=VSP_002049;
CC       Name=3;
CC         IsoId=Q9NTK5-3; Sequence=VSP_002050, VSP_002051;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues tested but its expression
CC       is more abundant in testis, liver, lung, and brain. Overexpressed in
CC       several malignancies, including cancers of the colon, rectum, ovary,
CC       lung, stomach, and uterus.
CC   -!- INDUCTION: Strongly down-regulated by DNA damage-inducing agents.
CC       {ECO:0000269|PubMed:20053727}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class OBG-HflX-like GTPase
CC       superfamily. OBG GTPase family. YchF/OLA1 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03167}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ250006; ABB72766.1; -; mRNA.
DR   EMBL; AF134478; AAP97255.1; -; mRNA.
DR   EMBL; AL136546; CAB66481.1; -; mRNA.
DR   EMBL; AF078859; AAD44491.1; -; mRNA.
DR   EMBL; AF078868; AAD44500.1; -; mRNA.
DR   EMBL; AF116703; AAF71123.1; -; mRNA.
DR   EMBL; AK027523; BAB55174.1; -; mRNA.
DR   EMBL; AK074710; BAC11153.1; -; mRNA.
DR   EMBL; CH471058; EAX11151.1; -; Genomic_DNA.
DR   EMBL; BC012842; AAH12842.1; -; mRNA.
DR   EMBL; BC013925; AAH13925.1; -; mRNA.
DR   EMBL; BC029376; AAH29376.1; -; mRNA.
DR   EMBL; BC091522; AAH91522.1; -; mRNA.
DR   CCDS; CCDS2255.1; -. [Q9NTK5-1]
DR   CCDS; CCDS42779.1; -. [Q9NTK5-2]
DR   PIR; T46901; T46901.
DR   RefSeq; NP_001011708.1; NM_001011708.3. [Q9NTK5-2]
DR   RefSeq; NP_037473.3; NM_013341.4. [Q9NTK5-1]
DR   PDB; 2OHF; X-ray; 2.70 A; A=1-396.
DR   PDBsum; 2OHF; -.
DR   AlphaFoldDB; Q9NTK5; -.
DR   SMR; Q9NTK5; -.
DR   BioGRID; 118917; 146.
DR   DIP; DIP-34591N; -.
DR   FunCoup; Q9NTK5; 1993.
DR   IntAct; Q9NTK5; 34.
DR   MINT; Q9NTK5; -.
DR   STRING; 9606.ENSP00000284719; -.
DR   ChEMBL; CHEMBL4105704; -.
DR   GlyGen; Q9NTK5; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9NTK5; -.
DR   MetOSite; Q9NTK5; -.
DR   PhosphoSitePlus; Q9NTK5; -.
DR   SwissPalm; Q9NTK5; -.
DR   BioMuta; OLA1; -.
DR   DMDM; 25453240; -.
DR   OGP; Q9NTK5; -.
DR   jPOST; Q9NTK5; -.
DR   MassIVE; Q9NTK5; -.
DR   PaxDb; 9606-ENSP00000284719; -.
DR   PeptideAtlas; Q9NTK5; -.
DR   ProteomicsDB; 82622; -. [Q9NTK5-1]
DR   ProteomicsDB; 82623; -. [Q9NTK5-2]
DR   ProteomicsDB; 82624; -. [Q9NTK5-3]
DR   Pumba; Q9NTK5; -.
DR   Antibodypedia; 19452; 285 antibodies from 28 providers.
DR   DNASU; 29789; -.
DR   Ensembl; ENST00000284719.8; ENSP00000284719.3; ENSG00000138430.16. [Q9NTK5-1]
DR   Ensembl; ENST00000344357.9; ENSP00000340167.5; ENSG00000138430.16. [Q9NTK5-2]
DR   Ensembl; ENST00000428402.6; ENSP00000410385.2; ENSG00000138430.16. [Q9NTK5-3]
DR   GeneID; 29789; -.
DR   KEGG; hsa:29789; -.
DR   MANE-Select; ENST00000284719.8; ENSP00000284719.3; NM_013341.5; NP_037473.3.
DR   UCSC; uc002uih.4; human. [Q9NTK5-1]
DR   AGR; HGNC:28833; -.
DR   CTD; 29789; -.
DR   DisGeNET; 29789; -.
DR   GeneCards; OLA1; -.
DR   HGNC; HGNC:28833; OLA1.
DR   HPA; ENSG00000138430; Low tissue specificity.
DR   MIM; 611175; gene.
DR   neXtProt; NX_Q9NTK5; -.
DR   OpenTargets; ENSG00000138430; -.
DR   PharmGKB; PA162398388; -.
DR   VEuPathDB; HostDB:ENSG00000138430; -.
DR   eggNOG; KOG1491; Eukaryota.
DR   GeneTree; ENSGT00390000000673; -.
DR   HOGENOM; CLU_018395_1_0_1; -.
DR   InParanoid; Q9NTK5; -.
DR   OrthoDB; 424823at2759; -.
DR   PAN-GO; Q9NTK5; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9NTK5; -.
DR   TreeFam; TF300774; -.
DR   PathwayCommons; Q9NTK5; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   SignaLink; Q9NTK5; -.
DR   BioGRID-ORCS; 29789; 178 hits in 1157 CRISPR screens.
DR   CD-CODE; 8C2F96ED; Centrosome.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; OLA1; human.
DR   EvolutionaryTrace; Q9NTK5; -.
DR   GeneWiki; OLA1; -.
DR   GenomeRNAi; 29789; -.
DR   Pharos; Q9NTK5; Tchem.
DR   PRO; PR:Q9NTK5; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9NTK5; protein.
DR   Bgee; ENSG00000138430; Expressed in cervix squamous epithelium and 212 other cell types or tissues.
DR   ExpressionAtlas; Q9NTK5; baseline and differential.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005737; C:cytoplasm; IDA:LIFEdb.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IDA:HGNC-UCL.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IDA:BHF-UCL.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0005525; F:GTP binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043023; F:ribosomal large subunit binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0046034; P:ATP metabolic process; IDA:BHF-UCL.
DR   CDD; cd04867; TGS_YchF_OLA1; 1.
DR   CDD; cd01900; YchF; 1.
DR   FunFam; 1.10.150.300:FF:000003; Obg-like ATPase 1; 1.
DR   FunFam; 3.10.20.30:FF:000029; Obg-like ATPase 1; 1.
DR   Gene3D; 3.10.20.30; -; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 1.10.150.300; TGS-like domain; 1.
DR   HAMAP; MF_00944; YchF_OLA1_ATPase; 1.
DR   InterPro; IPR004396; ATPase_YchF/OLA1.
DR   InterPro; IPR012675; Beta-grasp_dom_sf.
DR   InterPro; IPR031167; G_OBG.
DR   InterPro; IPR006073; GTP-bd.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR004095; TGS.
DR   InterPro; IPR012676; TGS-like.
DR   InterPro; IPR023192; TGS-like_dom_sf.
DR   InterPro; IPR013029; YchF_C.
DR   InterPro; IPR041706; YchF_N.
DR   NCBIfam; TIGR00092; redox-regulated ATPase YchF; 1.
DR   PANTHER; PTHR23305; OBG GTPASE FAMILY; 1.
DR   PANTHER; PTHR23305:SF11; OBG-LIKE ATPASE 1; 1.
DR   Pfam; PF01926; MMR_HSR1; 1.
DR   Pfam; PF06071; YchF-GTPase_C; 1.
DR   PIRSF; PIRSF006641; CHP00092; 1.
DR   PRINTS; PR00326; GTP1OBG.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF81271; TGS-like; 1.
DR   PROSITE; PS51710; G_OBG; 1.
DR   PROSITE; PS51880; TGS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding; Cytoplasm;
KW   Hydrolase; Magnesium; Metal-binding; Nucleotide-binding; Nucleus;
KW   Proteomics identification; Reference proteome.
FT   CHAIN           1..396
FT                   /note="Obg-like ATPase 1"
FT                   /id="PRO_0000122456"
FT   DOMAIN          23..283
FT                   /note="OBG-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01047"
FT   DOMAIN          304..387
FT                   /note="TGS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01228"
FT   MOTIF           267..274
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03167"
FT   BINDING         32..37
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000305|PubMed:17430889"
FT   BINDING         36
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01047"
FT   BINDING         56
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01047"
FT   BINDING         231
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000305|PubMed:17430889"
FT   MOD_RES         294
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   VAR_SEQ         1..158
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.5"
FT                   /id="VSP_002049"
FT   VAR_SEQ         245..278
FT                   /note="IKIKEWVDKYDPGALVIPFSGALELKLQELSAEE -> LESTDNKAEIILLK
FT                   MEILSSSNLTHLNNRRRNKI (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_002050"
FT   VAR_SEQ         279..396
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_002051"
FT   VARIANT         168
FT                   /note="E -> Q (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036613"
FT   MUTAGEN         127
FT                   /note="F->A: Loss of ATP-binding."
FT                   /evidence="ECO:0000269|PubMed:17430889"
FT   MUTAGEN         230
FT                   /note="N->A: Loss of ATP-binding."
FT                   /evidence="ECO:0000269|PubMed:17430889"
FT   MUTAGEN         231..233
FT                   /note="LSE->KSD: Retention of ATP-binding specificity."
FT                   /evidence="ECO:0000269|PubMed:17430889"
FT   CONFLICT        33
FT                   /note="V -> A (in Ref. 6; BAB55174)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        97
FT                   /note="V -> A (in Ref. 4; AAD44500)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        254
FT                   /note="Y -> C (in Ref. 3; CAB66481)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        391
FT                   /note="Q -> R (in Ref. 5; AAF71123)"
FT                   /evidence="ECO:0000305"
FT   STRAND          19..21
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   STRAND          25..28
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   STRAND          31..34
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           35..43
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   STRAND          60..65
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           69..78
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   STRAND          81..84
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   STRAND          87..92
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           109..115
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   STRAND          117..125
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           142..165
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           182..192
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           200..202
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           208..217
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           220..222
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   STRAND          225..230
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           233..238
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           242..254
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   STRAND          259..263
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           265..273
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           276..285
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           292..302
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   STRAND          305..322
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           327..332
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           337..341
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   STRAND          342..348
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           350..356
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   HELIX           359..364
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   STRAND          369..371
FT                   /evidence="ECO:0007829|PDB:2OHF"
FT   STRAND          382..387
FT                   /evidence="ECO:0007829|PDB:2OHF"
SQ   SEQUENCE   396 AA;  44744 MW;  4C7629BFC27CBEB2 CRC64;
     MPPKKGGDGI KPPPIIGRFG TSLKIGIVGL PNVGKSTFFN VLTNSQASAE NFPFCTIDPN
     ESRVPVPDER FDFLCQYHKP ASKIPAFLNV VDIAGLVKGA HNGQGLGNAF LSHISACDGI
     FHLTRAFEDD DITHVEGSVD PIRDIEIIHE ELQLKDEEMI GPIIDKLEKV AVRGGDKKLK
     PEYDIMCKVK SWVIDQKKPV RFYHDWNDKE IEVLNKHLFL TSKPMVYLVN LSEKDYIRKK
     NKWLIKIKEW VDKYDPGALV IPFSGALELK LQELSAEERQ KYLEANMTQS ALPKIIKAGF
     AALQLEYFFT AGPDEVRAWT IRKGTKAPQA AGKIHTDFEK GFIMAEVMKY EDFKEEGSEN
     AVKAAGKYRQ QGRNYIVEDG DIIFFKFNTP QQPKKK
//
